Health Care & Life Sciences » Biotechnology | Anavex Life Sciences Corp.

Anavex Life Sciences Corp. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
0.60
0.80
1.00
1.30
-
-
Gross Income
0.60
0.80
1.00
1.30
-
-
SG&A Expense
2,136.80
2,968.20
7,107.70
15,587.80
15,680.40
19,333.60
EBIT
2,137.40
-
7,108.70
15,589.00
15,680.40
19,333.60
Unusual Expense
1,457.20
199.70
84.80
212.60
75.20
-
Non Operating Income/Expense
54.10
33.00
70.60
48.40
47.60
80.70
Interest Expense
51.30
8,632.10
5,154.80
-
-
-
Pretax Income
3,700.00
11,368.40
12,108.10
14,707.10
15,423.70
19,010.20
Income Tax
-
1,400.00
-
29.60
1,963.30
1,556.80
Consolidated Net Income
3,700.00
9,968.40
12,108.10
14,736.70
13,460.40
17,453.40
Net Income
3,700.00
9,968.40
12,108.10
14,736.70
13,460.40
17,453.40
Net Income After Extraordinaries
3,700.00
9,968.40
12,108.10
14,736.70
13,460.40
17,453.40
Net Income Available to Common
3,700.00
9,968.40
12,108.10
14,736.70
13,460.40
17,453.40
EPS (Basic)
0.46
1.02
0.65
0.42
0.33
0.39
Basic Shares Outstanding
7,977.10
9,804.50
18,584.80
35,153.40
40,841.00
44,655.70
EPS (Diluted)
0.46
1.02
0.65
0.42
0.33
0.39
Diluted Shares Outstanding
7,977.10
9,804.50
18,584.80
35,153.40
40,841.00
44,655.70
EBITDA
2,136.80
2,968.20
7,107.70
15,587.80
15,680.40
19,333.60
Non-Operating Interest Income
-
-
-
5.50
88.10
255.10

About Anavex Life Sciences

View Profile
Address
51 West 52nd Street
New York New York 10019
United States
Employees -
Website http://www.anavex.com
Updated 07/08/2019
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.